CAC SBT 15 GR Decrement 5 News - CSG5D

Travere Therapeutics Shares Touch 52-Week Low on FSGS Study Data

By Colin Kellaher Shares of Travere Therapeutics tumbled nearly 35% and hit a new 52-week low Tuesday after the biopharmaceutical company said a...

Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration

By Chris Wack Arcturus Therapeutics Holdings Inc. shares were up 31% to $24.03 after it entered into a strategic collaboration with CSL Seqirus...

Arcturus Up 26% After Hours on CSL Seqirus Vaccine Collaboration

By Josh Beckerman Arcturus Therapeutics Holdings Inc. shares rose 26% to $23.10 after hours as the company announced a vaccine collaboration with...

Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220307005938/en/ AD...

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

By Joshua Kirby Shares in Vifor Pharma AG rose sharply in opening trade Tuesday after receiving an offer from Australia's CSL Ltd. that...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it has made a US$11.7 billion all-cash offer for Switzerland's...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. has made an all-cash offer for Vifor Pharma Ltd. that values the Swiss...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the...

CSL in Talks With Vifor Pharma Over Potential Transaction

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it is in talks with Vifor Pharma Ltd. over a potential acquisition of...

Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests

By Mike Cherney SYDNEY -- A Covid-19 vaccine candidate in Australia has been scrapped because recipients returned false positives on certain HIV...

CSL Signs 2 Initial Agreements for Coronavirus Vaccine Supply

By David Winning SYDNEY--CSL Ltd., Australia's largest pharmaceutical company, said it had signed initial deals for the supply of vaccines...

Coronavirus Pandemic Slashes Donations of Lifesaving Plasma

By Mike Cherney SYDNEY--Collections of blood plasma have fallen sharply in recent months because of the coronavirus pandemic, raising worries...

CSL Bering Gets FDA Orphan Designation for Hizentra

By Colin Kellaher CSL Ltd.'s (CSL.AU) CSL Behring unit Monday said it received orphan-drug exclusivity from the U.S. Food and Drug...

Haemonetics Cuts Guidance on CSL Plasma Deal

By Michael Dabaie Haemonetics Corp. (HAE) cut its fiscal 2020 revenue and per-share earnings forecast to reflect the pending transfer of ownership...

Seqirus Gets FDA Approval for Afluria Quadrivalent in Young Children

By Chris Wack Seqirus said Tuesday that the U.S. Food and Drug Administration has approved Afluria Quadrivalent, an influenza vaccine, for use in...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CAC SBT 15 GR Decrement 5 (CSG5D)

Professional-Grade Tools, for Individual Investors.

CSG5D News

Travere Therapeutics Shares Touch 52-Week Low on FSGS Study Data

Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration

Arcturus Up 26% After Hours on CSL Seqirus Vaccine Collaboration

Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

CSL in Talks With Vifor Pharma Over Potential Transaction

Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests

CSL Signs 2 Initial Agreements for Coronavirus Vaccine Supply

Coronavirus Pandemic Slashes Donations of Lifesaving Plasma

CSL Bering Gets FDA Orphan Designation for Hizentra

Haemonetics Cuts Guidance on CSL Plasma Deal

Seqirus Gets FDA Approval for Afluria Quadrivalent in Young Children

CSG5D Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CAC SBT 15 GR Decrement 5 (CSG5D) News

CAC SBT 15 GR Decrement 5 (CSG5D)

Professional-Grade Tools, for Individual Investors.

CSG5D News

Travere Therapeutics Shares Touch 52-Week Low on FSGS Study Data

Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration

Arcturus Up 26% After Hours on CSL Seqirus Vaccine Collaboration

Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

CSL in Talks With Vifor Pharma Over Potential Transaction

Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests

CSL Signs 2 Initial Agreements for Coronavirus Vaccine Supply

Coronavirus Pandemic Slashes Donations of Lifesaving Plasma

CSL Bering Gets FDA Orphan Designation for Hizentra

Haemonetics Cuts Guidance on CSL Plasma Deal

Seqirus Gets FDA Approval for Afluria Quadrivalent in Young Children

CSG5D Discussion

Your Recent History